Jeffrey Anderson

Jeffrey Anderson was appointed as President in March 2019. Prior to that, he served as our Senior Vice President of Clinical and Regulatory Affairs since December 2013, overseeing all aspects of the clinical evaluation and regulatory approval of the Company’s products as well as the commercial launch in several key markets. Previously, he served as the Vice President of Clinical and Regulatory Affairs from 2004 to 2008, and again from February 2011 until his promotion to Senior Vice President.

He has over 25 years of experience in the medical device industry, including his positions of Vice President of Clinical & Regulatory Affairs and Vice President of Research & Development for Neomend, a biomedical device company engaged in the development and commercialization of surgical wound healing products, where he served from October 2008 through February 2011. Additionally, Mr. Anderson has held senior positions at Abbott Vascular, Jomed, CRS Clinical Research, and Medtronic. He received his B.S. in Physics from California State University at Fullerton.